top of page
Cancer Blog
- Dr. Robert Nagourney -
Search


Small Comfort for Inoperable Pancreatic Cancer Patients
Patients never have a second chance to receive first-line therapy, yet first-line therapy offers the best chance of durable remission.

Dr. Robert A. Nagourney, MD
Jun 91 min read


What Medical Oncologists Aren’t Telling You About Chemotherapy
These results confirm that the majority of cancer patients in the US today do not respond to the NCCN guideline therapies that their physici

Dr. Robert A. Nagourney, MD
Apr 83 min read


5 Hidden Truths About Cancer Treatment That Functional Profiling Solves
Your life is too important to rely on statistical averages. Get the personalized approach you deserve.

Dr. Robert A. Nagourney, MD
Mar 123 min read


For Advanced Biliary Tract Cancer Patients, the Path Forward
Biliary tract cancer afflicts 8,000 patients in the US each year. It is separated into intrahepatic and and extrahepatic.

Dr. Robert A. Nagourney, MD
Feb 253 min read


Revolutionizing Breast Cancer Screening: The Promise of Metabolomics
metabolomics are poised to revolutionize breast cancer screening by enhancing diagnostic accuracy and reducing patient discomfort.

Dr. Robert A. Nagourney, MD
Jan 202 min read


Why Do Chemotherapy Drugs Work For Some Cancer Patients and Not For Others?
Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

Dr. Robert A. Nagourney, MD
Nov 19, 20243 min read


Metastatic Breast Cancer Claims Another Life
I received a video from an episode of Americas Got Talent, the popular TV program that features up-and-coming performers.

Dr. Robert A. Nagourney, MD
Sep 26, 20242 min read


Stage 4 Cancer Patients Need Answers Not Questions: Genomic Variants Of Uncertain Significance (VUS) Don’t Help!
Genomic findings are a first step. They find targets. The question the patient wants to answer is “Can I hit the target?”

Dr. Robert A. Nagourney, MD
Sep 5, 20243 min read


For Pancreatic Cancer Patients, “the More You Explain It, The More I Don’t Understand It.” -Mark Twain
Even here in the potentially curable
pancreatic cancer patients, there is a great deal of disagreement on the best treatment.

Dr. Robert A. Nagourney, MD
Jun 13, 20242 min read


What’s a Pancreatic Cancer Doctor to do? More Importantly: What are Their Patients to do?
Screening for Pancreatic cancer, even in the highest-risk individuals found not cost effective.

Dr. Robert A. Nagourney, MD
Mar 12, 20242 min read


Breakthrough in Pancreatic Cancer: New Blood Test for Early Detection, Could Offer Improved Therapy
Blood test results offer a “cancer signature” that distinguishes patients with pancreatic cancer from normal individuals.

Dr. Robert A. Nagourney, MD
Mar 4, 20242 min read


Much Heralded New Treatment For Pancreatic Cancer Approved by FDA: But Has it Moved The Dial?
The NAPOLI-3 trail trial median survival of 11.1 months is exactly the same as the original FOLFIRINOX regimen from 13 years ago.

Dr. Robert A. Nagourney, MD
Feb 21, 20242 min read


Functional Profiling for Cancer is Scientifically Validated by Peer-Review
One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.

Dr. Robert A. Nagourney, MD
Feb 9, 20242 min read


What Have Medical Oncologists Lost? Empathy!
Cancer patients approach their diagnosis with a sense of terror. One day they are fine and feeling well and the next, a terminal diagnosis.

Dr. Robert A. Nagourney, MD
Jan 31, 20243 min read


For Advanced Cancer Patients: Whose Life is It Anyway?
Rising corporate influence and focus on reimbursement in medicine now discourage doctors from straying from strict treatment guidelines.

Dr. Robert A. Nagourney, MD
Jan 23, 20243 min read


Personalized Medicine Is More Than a Marketing Buzzword at Nagourney Cancer Institute
Cancer therapy can be really expensive. But here's the kicker, Functional Profiling costs way less than receiving the incorrect treatment.

Dr. Robert A. Nagourney, MD
Jan 15, 20242 min read


The Cancer Clinical Trial Process is in Need of Revision
Patients with advanced malignancies often seek the expertise of physicians at major institutions.

Dr. Robert A. Nagourney, MD
Dec 7, 20232 min read


Hitting Cancer True and Straight: the Role of Tissue Analysis
Although she showed some response, her disease persisted and she was being considered for surgery to remove the residual tumor...

Dr. Robert A. Nagourney, MD
Oct 30, 20233 min read


Your Cancer Cure May Already Exist
Personalized treatment means more cured patients. More people survive cancer when our Functional Profiling system is used before treatment.

Dr. Robert A. Nagourney, MD
Sep 26, 20232 min read


Pancreatic Cancer Surgery: Know What You Have Consented To!
However, a new dilemma has arisen; the failure of surgeons to comply with Pancreatic Cancer patient’s wishes to have tissue submitted.

Dr. Robert A. Nagourney, MD
Aug 30, 20232 min read
bottom of page